NOVARTIS AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102 USD | +0.01% |
|
+7.11% | +2.00% |
| 05-13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
| 05-10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-05-08 | 2024-05-09 | 2024-05-10 | 2024-05-13 | |
|---|---|---|---|---|
| Last | 99.54 $ | 96.68 $ | 101.99 $ | 102 $ |
| Volume | 932 | 492 | 47 189 | 52 370 |
| Change | +3.40% | -2.87% | +5.49% | +0.01% |
| Opening | 99.54 | 96.68 | 101.90 | 102.00 |
| High | 99.54 | 96.68 | 101.99 | 102.00 |
| Low | 99.54 | 96.68 | 101.90 | 102.00 |
Performance
| 1 day | +0.01% | ||
| 1 week | +7.11% | ||
| Current month | +5.15% | ||
| 1 month | +8.93% | ||
| 3 months | +1.24% | ||
| 6 months | +11.17% | ||
| Current year | +2.00% | ||
| 1 year | -2.06% | ||
| 3 years | +17.11% | ||
| 5 years | +26.54% | ||
| 10 years | +15.51% |
Volumes
marketsDaily volume
52 370
Estimated daily volume
177 013
Avg. Volume 20 sessions
21 695
Daily volume ratio
8.16
Avg. Volume 20 sessions USD
2 212 890.00
Record volume 1
7 964 890
Record volume 2
1 220 956
Record volume 3
1 198 473
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
209 219 996 957
Net sales (USD)
45 440 000 000
Number of employees
76 057
Sales / Employee (USD)
597 447
Free-Float
85.22 %
Free-Float capitalization (USD)
191 371 197 116
Average Daily Capital Traded
0%
Highs and lows
1 week
96.68
102.00
1 month
90.24102.00
Current year
90.24109.00
1 year
90.24109.00
3 years
72.98109.00
5 years
68.65109.00
10 years
66.35109.00
Indicators
Moving average 5 days
99.30
Moving average 20 days
48.14
Moving average 50 days
52.13
Moving average 100 days
99.82
Price spread / (MMA5)
-2.65%
Price spread / (MMA20)
-52.80%
Price spread / (MMA50)
-48.89%
Price spread / (MMA100)
-2.14%
STIM
RSI 9 days
57.25
RSI 14 days
54.42
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.01% | +7.11% | +2.00% | -2.06% | 209B | ||
| -0.36% | -2.72% | +29.80% | +74.13% | 682B | ||
| +0.01% | +3.10% | +30.35% | +56.63% | 586B | ||
| -0.24% | +1.56% | -3.63% | -5.33% | 364B | ||
| -0.83% | -1.54% | +17.75% | +10.31% | 327B | ||
| -0.55% | -1.06% | +3.77% | +9.71% | 285B | ||
| -0.52% | +1.14% | +15.62% | +2.13% | 240B | ||
| -1.65% | +1.22% | -8.38% | -21.20% | 203B | ||
| +0.02% | +2.80% | +7.18% | +32.19% | 165B | ||
| -0.23% | +2.12% | -1.49% | -23.68% | 161B | ||
| -1.10% | -0.21% | +2.15% | -8.02% | 125B | ||
| +0.08% | +2.80% | +24.83% | +23.18% | 92.65B | ||
| -0.77% | +1.49% | -12.89% | -34.44% | 91.34B | ||
| -0.53% | +2.61% | -17.08% | -14.30% | 84.14B | ||
| -0.13% | -1.58% | +39.85% | +17.72% | 66.54B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | -0.43% | +2.04% | +8.65% | +7.80% | ||
| Weighted average by Cap. | -0.40% | +2.06% | +13.50% | +22.61% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +2.00% | ||
| 2023 | +8.87% | ||
| 2022 | +5.01% | ||
| 2021 | -6.80% | ||
| 2020 | -0.90% | ||
| 2019 | +12.74% | ||
| 2018 | -0.83% | ||
| 2017 | +16.79% | ||
| 2016 | -16.65% | ||
| 2015 | -6.82% | ||
| 2014 | +16.07% | ||
| 2013 | +28.00% | ||
| 2012 | +9.10% | ||
| 2011 | -2.02% | ||
| 2010 | +3.35% | ||
| 2009 | +13.79% | ||
| 2008 | -8.26% | ||
| 2007 | -5.79% | ||
| 2006 | +9.36% | ||
| 2005 | +5.27% | ||
| 2004 | +12.79% | ||
| 2003 | +10.68% |
- Stock Market
- Equities
- NOVN Stock
- NVSEF Stock
- Quotes Novartis AG
